JP2024500360A5 - - Google Patents

Info

Publication number
JP2024500360A5
JP2024500360A5 JP2023535468A JP2023535468A JP2024500360A5 JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5 JP 2023535468 A JP2023535468 A JP 2023535468A JP 2023535468 A JP2023535468 A JP 2023535468A JP 2024500360 A5 JP2024500360 A5 JP 2024500360A5
Authority
JP
Japan
Prior art keywords
poly
polymerosomes
seq
peo
populations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023535468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024500360A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/085366 external-priority patent/WO2022123070A1/en
Publication of JP2024500360A publication Critical patent/JP2024500360A/ja
Publication of JP2024500360A5 publication Critical patent/JP2024500360A5/ja
Pending legal-status Critical Current

Links

JP2023535468A 2020-12-11 2021-12-13 関連づけられた抗原および関連づけられたアジュバントを有する2つのポリマーソーム集団を投与することによる、Th1/Th2免疫応答の調整方法 Pending JP2024500360A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20213488 2020-12-11
EP20213488.8 2020-12-11
PCT/EP2021/085366 WO2022123070A1 (en) 2020-12-11 2021-12-13 Modulating th1/th2 immune response by administering two populations of polymersomes having an associated antigen and an associated adjuvant

Publications (2)

Publication Number Publication Date
JP2024500360A JP2024500360A (ja) 2024-01-09
JP2024500360A5 true JP2024500360A5 (cg-RX-API-DMAC10.html) 2024-07-11

Family

ID=74187071

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535468A Pending JP2024500360A (ja) 2020-12-11 2021-12-13 関連づけられた抗原および関連づけられたアジュバントを有する2つのポリマーソーム集団を投与することによる、Th1/Th2免疫応答の調整方法

Country Status (6)

Country Link
US (1) US20230398207A1 (cg-RX-API-DMAC10.html)
EP (1) EP4259197A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024500360A (cg-RX-API-DMAC10.html)
AU (1) AU2021396659A1 (cg-RX-API-DMAC10.html)
CA (1) CA3193643A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022123070A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111450060A (zh) * 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
WO2024086380A2 (en) * 2022-10-21 2024-04-25 Pds Biotechnology Corporation Recombinant protein vaccines formulated with enantio-specific cationic lipid r-dotap and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354934A (en) 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
WO2009127537A1 (en) 2008-04-17 2009-10-22 GÜNZBURG, Walter Post release modification of viral envelopes
US8323696B2 (en) 2008-08-29 2012-12-04 Ecole Polytechnique Federale De Lausanne Nanoparticles for immunotherapy
US10364350B2 (en) 2009-04-20 2019-07-30 Agency For Science, Technology And Research Vesicular system and uses thereof
WO2012018306A1 (en) 2010-08-05 2012-02-09 Agency For Science, Technology And Research A multicompartmentalized vesicular structure and a method for forming the same
CA3170184A1 (en) 2012-03-12 2013-09-19 Advanced Bioadjuvants, Llc Adjuvant and vaccine compositions
US20150233800A1 (en) 2012-10-11 2015-08-20 Vin-De-Bona Trading Company Pte Ltd Method of painting microvesicles
CN111450060A (zh) 2012-11-19 2020-07-28 新加坡科技研究局 用于引发对免疫原的免疫响应的方法
KR20200039025A (ko) * 2013-09-19 2020-04-14 조에티스 서비시즈 엘엘씨 유성 아쥬반트
EP2898894A1 (en) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-micro particles for intradermal delivery
WO2016154432A1 (en) 2015-03-24 2016-09-29 VaxLiant, LLC Adjuvant compositions and related methods
US10696985B1 (en) * 2016-06-06 2020-06-30 Vanderbilt University Reversibly crosslinked endosomolytic polymer vesicles for cytosolic drug delivery
JP7542257B2 (ja) * 2018-01-25 2024-08-30 エイシーエム バイオラブズ プライベート リミテッド 可溶化された封入抗原を含むポリマーソーム、ならびにその作製および使用方法
CA3143533A1 (en) * 2019-08-01 2021-02-04 Madhavan Nallani A method of eliciting an immune response by administering a population of polymersomes having an associated antigen together with a population of polymersomes having an associated adjuvant as well as compositions comprising the two populations of polymersome
WO2021214339A2 (en) * 2020-04-24 2021-10-28 Acm Biolabs Pte Ltd Vaccine against human-pathogenic coronaviruses

Similar Documents

Publication Publication Date Title
JP2022543038A5 (cg-RX-API-DMAC10.html)
US20080124350A1 (en) Nanoparticle-based vaccine delivery system containing adjuvant
US6359054B1 (en) Polynucleotide compositions for intramuscular administration
CN114728154A (zh) 基于丝素蛋白的微针及其用途
Yang et al. Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori
TR201904758T4 (tr) İmmünoterapiye yönelik RNA formülasyonu.
JP2021512142A5 (cg-RX-API-DMAC10.html)
CN112118847A (zh) 包含突变kras序列和脂质的化合物及其用途
US9750692B2 (en) Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
US7256180B2 (en) Compositions and methods for inducing activation of dendritic cells
Hassan et al. From antigen uptake to immune modulation: The multifaceted potential of peptide nanofibers as vaccine nanocarriers
US20250235532A1 (en) Polymer-lipid hybrid nanoparticles comprising a lipid and a block copolymer as well as methods of making and uses thereof
CN118055775A (zh) 包括hsp90抗原肽的抗癌用疫苗组合物及其用途
Singh et al. Applications of nanotechnology in vaccine delivery
US20240181070A1 (en) Nanovaccines for treatment of viral diseases
WO2001083698A2 (en) Compositions and methods for inducing activation of dendritic cells
CN120769913A (zh) 基于核酸的癌症疫苗及其方法
US20220370488A1 (en) Mucus penetrating particle compositions and methods of use thereof enhancing immune response
JP2024505964A5 (cg-RX-API-DMAC10.html)
TW202108169A (zh) 裝載抗原決定位與佐劑之奈米粒子之疫苗、其製備方法及中和病毒感染方法
KR102901149B1 (ko) 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법
WO2024186646A1 (en) Methods of making lipid adjuvanted compositions
Khan et al. Nanovaccines against viral infections: Current trends and future prospects
Misra et al. Vaccine Design, Nanoparticle Vaccines and Biomaterial Applications
Votaw Polysequence Nanomaterials for Immunomodulation